275 related articles for article (PubMed ID: 29548053)
1. Concepts for Immunotherapies in Gliomas.
Platten M; Reardon DA
Semin Neurol; 2018 Feb; 38(1):62-72. PubMed ID: 29548053
[TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy in brain tumors].
De Carli E; Delion M; Rousseau A
Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
[TBL] [Abstract][Full Text] [Related]
3. Single vs. combination immunotherapeutic strategies for glioma.
Chandran M; Candolfi M; Shah D; Mineharu Y; Yadav VN; Koschmann C; Asad AS; Lowenstein PR; Castro MG
Expert Opin Biol Ther; 2017 May; 17(5):543-554. PubMed ID: 28286975
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
5. Cell- and peptide-based immunotherapeutic approaches for glioma.
Yamanaka R
Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
[TBL] [Abstract][Full Text] [Related]
6. Principles of immunotherapy.
Liebelt BD; Finocchiaro G; Heimberger AB
Handb Clin Neurol; 2016; 134():163-81. PubMed ID: 26948354
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for glioma: Current management and future application.
Xu S; Tang L; Li X; Fan F; Liu Z
Cancer Lett; 2020 Apr; 476():1-12. PubMed ID: 32044356
[TBL] [Abstract][Full Text] [Related]
8. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
Pollack IF; Okada H; Chambers WH
Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
[TBL] [Abstract][Full Text] [Related]
9. Concepts in glioma immunotherapy.
Platten M; Bunse L; Wick W; Bunse T
Cancer Immunol Immunother; 2016 Oct; 65(10):1269-75. PubMed ID: 27460064
[TBL] [Abstract][Full Text] [Related]
10. Advances in immunotherapeutic research for glioma therapy.
Miyauchi JT; Tsirka SE
J Neurol; 2018 Apr; 265(4):741-756. PubMed ID: 29209782
[TBL] [Abstract][Full Text] [Related]
11. Monitoring immune responses after glioma vaccine immunotherapy.
Jian B; Yang I; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):195-9. PubMed ID: 19944978
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of local immunoresistance in glioma.
Albesiano E; Han JE; Lim M
Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
[TBL] [Abstract][Full Text] [Related]
13. Concepts of immunotherapy for glioma.
Patel MA; Pardoll DM
J Neurooncol; 2015 Jul; 123(3):323-30. PubMed ID: 26070552
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
[TBL] [Abstract][Full Text] [Related]
15. Cellular immunity and immunotherapy of brain tumors.
Prins RM; Liau LM
Front Biosci; 2004 Sep; 9():3124-36. PubMed ID: 15353342
[TBL] [Abstract][Full Text] [Related]
16. [Brain tumor immunotherapy: Illusion or hope?].
Migliorini D; Dutoit V; Walker PR; Dietrich PY
Bull Cancer; 2017 May; 104(5):476-484. PubMed ID: 28318492
[TBL] [Abstract][Full Text] [Related]
17. Assessing Response of High-Grade Gliomas to Immune Checkpoint Inhibitors.
Sahebjam S; Stallworth DG; Mokhtari S; Tran ND; Arrington JA
Cancer Control; 2017 Apr; 24(2):180-186. PubMed ID: 28441372
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials in cellular immunotherapy for brain/CNS tumors.
Badhiwala J; Decker WK; Berens ME; Bhardwaj RD
Expert Rev Neurother; 2013 Apr; 13(4):405-24. PubMed ID: 23545055
[TBL] [Abstract][Full Text] [Related]
19. Immunobiology and immunotherapeutic targeting of glioma stem cells.
Madany M; Thomas TM; Edwards L; Yu JS
Adv Exp Med Biol; 2015; 853():139-66. PubMed ID: 25895711
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.
Yang L; Ng KY; Lillehei KO
Cancer Control; 2003; 10(2):138-47. PubMed ID: 12712008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
